par Bianchini, Giampaolo;Pusztai, Lajos;Karn, Thomas;Iwamoto, Takayuki;Rody, Achim;Kelly, Catherine M;Müller, Volkmar;Schmidt, Marcus;Qi, Yuan;Holtrich, Uwe;Becker, Sven;Santarpia, Libero;Fasolo, Angelica;Del Conte, Gianluca;Zambetti, Milvia;Sotiriou, Christos ;Haibe-Kains, Benjamin ;Symmans, W Fraser;Gianni, Luca
Référence Breast cancer research, 15, 5, page (R86)
Publication Publié, 2013-09
Référence Breast cancer research, 15, 5, page (R86)
Publication Publié, 2013-09
Article révisé par les pairs
Résumé : | We examined if a combination of proliferation markers and estrogen receptor (ER) activity could predict early versus late relapses in ER-positive breast cancer and inform the choice and length of adjuvant endocrine therapy. |